MeSH term
Frequency | Condition_Probility | Animals | 79 | 0.0 |
Base Sequence | 50 | 0.0 |
Cell Line | 7 | 0.0 |
Cell Lineage | 2 | 0.0 |
Cytoskeletal Proteins/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Gene Expression Regulation | 4 | 0.0 |
Humans | 140 | 0.0 |
Mice | 54 | 0.0 |
Molecular Sequence Data | 52 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 68 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Transcription Factors/*metabolism | 4 | 0.0 |
Adult | 10 | 0.0 |
Child, Preschool | 9 | 0.0 |
DNA-Binding Proteins/genetics | 12 | 1.0 |
Eyelids/*abnormalities | 2 | 33.0 |
Face/*abnormalities | 2 | 5.0 |
Female | 44 | 0.0 |
Male | 44 | 0.0 |
Mutation | 19 | 0.0 |
Syndrome | 4 | 0.0 |
*Transcription Factors | 50 | 3.0 |
Child | 18 | 0.0 |
Chromosome Banding | 2 | 0.0 |
Chromosome Mapping | 17 | 0.0 |
Chromosome Painting | 2 | 4.0 |
DNA-Binding Proteins/*genetics | 45 | 2.0 |
In Situ Hybridization, Fluorescence | 7 | 0.0 |
Karyotyping | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 94 | 0.0 |
Sequence Deletion | 10 | 0.0 |
*Translocation, Genetic | 11 | 1.0 |
Comparative Study | 12 | 0.0 |
DNA Primers | 11 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
*Gene Expression Regulation, Developmental | 11 | 1.0 |
*Gene Expression Regulation, Neoplastic | 6 | 0.0 |
Gene Library | 2 | 0.0 |
Gene Targeting | 2 | 0.0 |
Membrane Proteins/genetics | 2 | 0.0 |
Muscle Proteins/genetics | 2 | 2.0 |
Rhabdomyosarcoma, Alveolar/*genetics | 16 | 84.0 |
Transcription Factors/*genetics | 17 | 0.0 |
Tumor Cells, Cultured | 29 | 0.0 |
Actins/metabolism | 2 | 0.0 |
Adenoviridae/genetics/metabolism | 2 | 6.0 |
Cell Aggregation/*physiology | 2 | 40.0 |
Cell Size | 3 | 1.0 |
DNA-Binding Proteins/genetics/*metabolism | 12 | 1.0 |
Genes, Reporter | 5 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Osteosarcoma | 2 | 2.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
*Zebrafish Proteins | 3 | 1.0 |
COS Cells | 5 | 0.0 |
Hepatocyte Growth Factor/metabolism | 2 | 3.0 |
Phenotype | 18 | 0.0 |
Muscle, Skeletal/*cytology | 2 | 12.0 |
MyoD Protein/genetics | 3 | 21.0 |
*Trans-Activators | 4 | 0.0 |
Embryonic and Fetal Development | 3 | 0.0 |
Homeodomain Proteins/genetics/metabolism | 2 | 2.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Inbred C57BL | 9 | 0.0 |
Mice, Transgenic | 6 | 0.0 |
Promoter Regions (Genetics) | 12 | 0.0 |
Protein Binding | 5 | 0.0 |
Recombinant Fusion Proteins/metabolism | 4 | 0.0 |
Transcription Factors/genetics/metabolism | 4 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 3 | 1.0 |
*Gene Expression Regulation | 5 | 0.0 |
Waardenburg's Syndrome/genetics | 6 | 28.0 |
Chromosomes, Human, Pair 13 | 13 | 10.0 |
Chromosomes, Human, Pair 2 | 14 | 8.0 |
Plasmids | 3 | 0.0 |
Protein Biosynthesis | 3 | 0.0 |
Rhabdomyosarcoma/genetics | 2 | 15.0 |
Transcription Factors/genetics/*metabolism | 7 | 0.0 |
*Transcription, Genetic | 4 | 0.0 |
Transfection | 16 | 0.0 |
Translocation, Genetic | 15 | 1.0 |
In Situ Hybridization | 10 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
Exons/genetics | 3 | 0.0 |
Infant | 5 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Pedigree | 21 | 0.0 |
Polymorphism, Single-Stranded Conformational | 6 | 0.0 |
Protein Structure, Tertiary | 7 | 0.0 |
Waardenburg's Syndrome/*genetics | 24 | 63.0 |
DNA-Binding Proteins/genetics/metabolism | 4 | 0.0 |
Gene Expression Regulation, Neoplastic | 6 | 0.0 |
Models, Genetic | 3 | 0.0 |
Trans-Activation (Genetics) | 6 | 0.0 |
*Apoptosis | 2 | 0.0 |
DNA, Neoplasm/genetics | 3 | 0.0 |
*Gene Fusion | 2 | 11.0 |
Homeodomain Proteins/*genetics | 4 | 0.0 |
Prognosis | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Chromosomes, Human, Pair 2/*genetics | 4 | 2.0 |
Oncogene Proteins, Fusion/*genetics | 2 | 1.0 |
Trans-Activators/genetics | 2 | 0.0 |
Chick Embryo | 5 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Mice, Mutant Strains | 9 | 1.0 |
Mutation/*genetics | 2 | 0.0 |
Pregnancy | 3 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cells, Cultured | 6 | 0.0 |
DNA-Binding Proteins/*physiology | 5 | 0.0 |
Down-Regulation | 2 | 0.0 |
Genes, Dominant | 5 | 0.0 |
Homeodomain Proteins/*biosynthesis | 2 | 7.0 |
Models, Biological | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Transcription, Genetic | 11 | 0.0 |
DNA-Binding Proteins/*genetics/physiology | 2 | 2.0 |
Gene Expression | 5 | 0.0 |
Transcription Factors/*genetics/physiology | 2 | 2.0 |
*Drosophila Proteins | 2 | 0.0 |
Gene Expression Regulation, Developmental | 8 | 0.0 |
Introns/genetics | 2 | 0.0 |
*Nuclear Proteins | 3 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
Proto-Oncogene Protein c-kit/genetics | 2 | 5.0 |
Gestational Age | 3 | 0.0 |
MyoD Protein/*genetics | 2 | 18.0 |
Neoplasm Metastasis | 4 | 0.0 |
Conserved Sequence | 8 | 0.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 4 | 3.0 |
Genotype | 9 | 0.0 |
Hela Cells | 4 | 0.0 |
Mutagenesis | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Time Factors | 3 | 0.0 |
Disease Models, Animal | 8 | 0.0 |
Embryonic and Fetal Development/*genetics | 2 | 2.0 |
Nervous System/embryology | 3 | 9.0 |
Transcription Factors/genetics | 14 | 1.0 |
DNA-Binding Proteins/*genetics/metabolism | 5 | 1.0 |
High Mobility Group Proteins/*genetics/metabolism | 2 | 15.0 |
Transcription Factors/*genetics/metabolism | 4 | 1.0 |
Rhabdomyosarcoma/metabolism | 3 | 42.0 |
Transcription Factors/*physiology | 4 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Adolescent | 6 | 0.0 |
Waardenburg's Syndrome/classification/*genetics | 6 | 66.0 |
Chromosome Disorders | 2 | 0.0 |
Linkage (Genetics) | 6 | 0.0 |
*Cell Transformation, Neoplastic | 4 | 0.0 |
Disease Progression | 2 | 0.0 |
Neoplasm Invasiveness | 2 | 0.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
*Homeodomain Proteins | 13 | 4.0 |
Muscle Proteins/*genetics | 4 | 2.0 |
Nerve Tissue Proteins/*genetics | 3 | 0.0 |
Aged | 3 | 0.0 |
Middle Aged | 4 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Morphogenesis | 2 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 4 | 0.0 |
Amino Acid Sequence | 23 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Sequence Alignment | 6 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Exons | 9 | 0.0 |
3T3 Cells | 7 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Cloning, Molecular | 9 | 0.0 |
Rhabdomyosarcoma/*genetics | 5 | 23.0 |
Binding Sites | 8 | 0.0 |
Proto-Oncogene Protein c-met/genetics | 2 | 11.0 |
Genes, Homeobox/*genetics | 3 | 4.0 |
*T-Box Domain Proteins | 2 | 6.0 |
DNA-Binding Proteins/chemistry/*genetics | 2 | 2.0 |
Muscle Proteins/chemistry/*genetics | 2 | 11.0 |
Nerve Tissue Proteins/chemistry/*genetics | 2 | 4.0 |
*Chromosome Aberrations | 3 | 0.0 |
Gene Rearrangement | 2 | 0.0 |
Neural Tube Defects/*genetics | 3 | 8.0 |
Genetic Markers | 7 | 0.0 |
Species Specificity | 3 | 0.0 |
Alleles | 6 | 0.0 |
Gene Frequency | 2 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Eye Abnormalities/genetics | 2 | 7.0 |
Mice, Mutant Strains/*genetics | 2 | 10.0 |
Cell Division | 2 | 0.0 |
Open Reading Frames | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Receptors, Estrogen/genetics/metabolism | 2 | 6.0 |
*Genes, Homeobox | 5 | 2.0 |
Polymerase Chain Reaction | 15 | 0.0 |
Embryonic and Fetal Development/genetics | 2 | 2.0 |
Multigene Family | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 2 | 2.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Homeodomain Proteins/metabolism | 2 | 2.0 |
Central Nervous System/embryology | 2 | 11.0 |
Homeodomain Proteins/genetics | 2 | 0.0 |
*Trans-Activation (Genetics) | 3 | 0.0 |
Family | 3 | 0.0 |
Point Mutation | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
*Mutation | 9 | 0.0 |
Introns | 6 | 0.0 |
*Gene Deletion | 2 | 0.0 |
Microsatellite Repeats | 2 | 0.0 |
Heterozygote | 5 | 0.0 |
*Homozygote | 2 | 1.0 |
Cell Movement | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Cell Survival/drug effects | 2 | 0.0 |
Chimeric Proteins/biosynthesis | 2 | 4.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
*Chromosomes, Human, Pair 13 | 5 | 2.0 |
Pigmentation Disorders/genetics | 2 | 14.0 |
Skull/*abnormalities | 2 | 10.0 |
*Chromosomes, Human, Pair 2 | 8 | 2.0 |
Restriction Mapping | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Transcription Factors/*biosynthesis/genetics | 2 | 2.0 |
Consensus Sequence | 2 | 0.0 |
Genes, Recessive | 2 | 0.0 |
DNA | 2 | 0.0 |
Rhabdomyosarcoma, Alveolar/*genetics/pathology | 2 | 50.0 |
Lod Score | 3 | 0.0 |
Neural Tube Defects/genetics | 2 | 18.0 |
Rhabdomyosarcoma, Alveolar/chemistry/*genetics | 2 | 100.0 |
Transcription Factors/biosynthesis/*genetics | 2 | 1.0 |
DNA, Satellite/genetics | 2 | 1.0 |
*Frameshift Mutation | 2 | 1.0 |
DNA, Complementary/genetics | 2 | 0.0 |
*Point Mutation | 4 | 0.0 |
*Genes, Structural | 2 | 0.0 |
DNA/genetics | 3 | 0.0 |
DNA-Binding Proteins/*biosynthesis/*genetics | 2 | 5.0 |
*Enhancer Elements (Genetics) | 2 | 0.0 |
Waardenburg's Syndrome/*genetics/physiopathology | 2 | 66.0 |
